NCT00164125已完成4 期
An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients
Braintree Laboratories47 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2003年7月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 300
- 试验地点
- 47
- 主要终点
- Safety (Adverse events and laboratory testing)
研究概览
简要总结
To evaluate the safety of extended use of polyethyleneglycol3350 laxative in constipated patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inclusion Criteria:
- •Male or female outpatients at least 18 years of age
- •Constipated according to ROME I criteria
- •If female and of childbearing potential, patient must be surgically sterilized or using oral contraceptives, depot contraceptives, intrauterine device, or testifies that she is monogamous with a vasectomized partner, or practices abstinence and will continue to do so during the duration of study
- •Are otherwise in good health, as judged by a physical examination
- •In the investigator's judgment, patient is mentally competent to sign an instrument of informed consent
排除标准
- •Patients with heme positive stool at screening. Patients with heme positive stool that can be attributed to hemorrhoids or anal fissures are eligible for inclusion.
- •Patients with hypo- or hyperthyroidism as determined by history, or screening TSH results.
- •Patients with known or suspected perforation or obstruction.
- •History of gastric retention, inflammatory bowel disease, bowel resection, or colostomy.
- •Patients with a known history of organic cause for their constipation.
- •Patients meeting the ROME definition of Irritable Bowel Syndrome
- •Patients currently taking any of the following medications that are known to effect bowel habits:
- •Antidiarrheals
- •Antacids containing magnesium or aluminum salts
- •Anticholinergics
- •Antispasmodic agents
- •Erythromycin and other macrolides
- •Octreotide
- •Lotronex, Zofran, or other 5-HT3 antagonists
- •Zelnorm, or other 5-HT4 agonists
- •Opiods/narcotic analgesics
- •Prokinetics
- •Serotonin re-uptake inhibitors or tricyclic antidepressants
- •Calcium antagonists
- •Patients who are breastfeeding, pregnant, or intend to become pregnant during the study.
- •Female patients of childbearing potential who refuse a pregnancy test.
- •Patients with a known allergy to polyethyleneglycol.
- •Patients who, in the opinion of the investigator, should not be included in the study for any reason, including inability to follow study procedures.
- •Patients who, within the past 30 days have participated in an investigational clinical study
结局指标
主要结局
Safety (Adverse events and laboratory testing)
次要结局
- Assessment of constipation using ROME I criteria and analysis of individual ROME I criteria
研究者
研究点 (47)
Loading locations...
相似试验
已完成
4 期
Extended Use of Polyethyleneglycol3350 Laxative in Constipated PatientsConstipationNCT00153153Braintree Laboratories300
已完成
3 期
An Open Label Study of Chronic Use of BLI400 Laxative in Constipated AdultsChronic Idiopathic ConstipationCICConstipationNCT02819310Braintree Laboratories330
已完成
4 期
PolyethyleneGlycol3350 Laxative vs Placebo in Constipated ChildrenConstipationNCT00153114Braintree Laboratories100
已完成
不适用
Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.Portosystemic EncephalopathyPSEHepatic EncephalopathyCirrhosisNCT01283152University of Texas Southwestern Medical Center50
Unknown
不适用
Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic ConstipationBowel PreparationNCT05137145Second Affiliated Hospital of Xi'an Jiaotong University300